期刊文献+

经皮冠状动脉介入术对冠心病患者血清同型半胱氨酸及半乳糖血凝素-3的影响与病情相关性分析 被引量:5

Influence of percutaneous coronary intervention on homocysteine and galection-3 in serum of patients with coronary heart disease and correlation analysis
原文传递
导出
摘要 目的探讨经皮冠状动脉介入(PCI)术对冠心病患者血清同型半胱氨酸(Hcy)及半乳糖血凝素-3(Galectin-3)的影响与病情相关性分析。方法选择2016年9月至2017年10月在济南市中心医院心内科行冠脉造影的冠心病患者70例,依照造影情况分为观察组47例:A型病变组25例,B型病变组22例,均置入涂有药物的支架;对照组23例:冠脉造影提示无需行PCI术。分别于手术前1d、术后1d和7d测定各组血浆Hcy、脑钠肽(BNP)及血清Galectin-3的浓度。追踪PCI术后患者,随访1年,观察血清Hcy及Galectin-3水平变化与冠心病的严重程度的相关性。结果PCI术后A组血Hcy浓度[(16.52±5.41)μmol/L]和B组血Hcy浓度[(19.32±6.35)μmol/L]较术前[(11.66±3.25)μmol/L、(15.87±5.20)μmol/L]均明显升高(t=2.375,P<0.05;t=2.97,P<0.01);同时术后A组血Galectin-3浓度[(0.86±0.11)μg/L]和B组血Galectin-3浓度[(1.15±0.48)μg/L]较术前[(0.32±0.53)μg/L、(0.46±0.19)μg/L]均升高(t=2.178,P<0.05;t=4.269,P<0.01);血清Hcy及Galectin-3的水平与冠心病严重程度呈正相关。结论血清Hcy及Galectin-3浓度于PCI术后较前明显升高,说明术中球囊对血管扩张和斑块挤压破坏,影响了Hcy、Galectin-3的上调及表达。血Hcy、Galectin-3水平对冠心病的诊断和病变程度的评价有一定的帮助。 Objective To discuss the influence of percutaneous coronary intervention(PCI) on the serum concentration of homocysteine(Hcy) and galectin-3 in patients with coronary heart disease(CHD). Methods From September 2016 to October 2017,70 patients in Ji'nan Central Hospital were selected.According to the results of coronary angiography(CAG),they were divided into observation group with drug-eluted stents(n=47,including 25 cases with type A CHD and 22 cases with type B CHD) and control group without abnormal CAG(n=23).Serial venous blood samples were obtained 1 day before PCI as well as 1 day and 7 days after PCI.Plasma concentrations of Hcy,BNP and galectin-3 were measured and compared.The postoperative patients with PCI were tracked for 1 year to observe the influence of serum Hcy and galectin-3 on the severity of CHD and the quality after PCI. Results The plasma Hcy levels of type A[(16.52±5.41)μmol/L]and type B[(19.32±6.35)μmol/L]after PCI were significantly higher than those of the type A[(11.66±3.25)μmol/L]and the type B[(15.87±5.20)μmol/L]before PCI(t=2.375,P<0.05,t=2.97,P<0.01).Meanwhile,the plasma galectin-3 levels of type A[(0.86±0.11)μg/L] and type B[(1.15±0.48)μg/L]after PCI were also higher than those of the type A[(0.32±0.53)μg/L]and the type B[(0.46±0.19)μg/L]before PCI(t=2.178,P<0.05,t=4.269,P<0.01).Furthermore,levels of the plasma Hcy and galectin-3 were positively associated with the severity of CHD. Conclusion The higher blood levels of serum Hcy,BNP and galectin-3 after PCI indicate that the balloon inflation and implantation of stent can affect the level of plasma Hcy,BNP and galectin-3.Therefore,the levels of serum Hcy and galectin-3 are helpful to diagnose CHD and evaluate the degree of CHD.
作者 朱耀辉 Zhu Yaohui(Department of Cardiology,Ji'nan Central Hospital,Jinan,Shandong 250013,China)
出处 《中国基层医药》 CAS 2018年第24期3202-3206,共5页 Chinese Journal of Primary Medicine and Pharmacy
关键词 冠状动脉疾病 经皮冠状动脉介入治疗 半胱氨酸 脑钠肽 半乳糖血凝素-3 冠状动脉造影 血清 病变程度 Coronary artery disease Percutaneous coronary intervention Cysteine Brain natriuretic peptide Galectin-3 Coronary angiography Serum Degree of the lesion
  • 相关文献

参考文献6

二级参考文献75

  • 1吴桂贤,吴兆苏,王薇,刘静,孙佳艺,刘军,赵冬.1992—2002年北京一组队列人群心血管病危险因素变化趋势研究[J].中华心血管病杂志,2005,33(8):748-753. 被引量:53
  • 2葛智儒,邱建平,陆纪德,龚佩华.女性高危急性冠脉综合征早期PCI预后分析[J].中国医药导刊,2006,8(3):160-161. 被引量:5
  • 3吕树铮,宋现涛,陈韵岱,陈欣,中国经皮冠状动脉介入治疗登记调查研究协作组.中国大陆2005年度经皮冠状动脉介入治疗登记调查研究结果初步分析[J].中华心血管病杂志,2006,34(11):966-970. 被引量:43
  • 4宋艳东,李志忠,张京梅,王苏,刘彤,陶英,孙涛,刘巍,阙斌,赵战勇,卢辛,王新.冠心病经皮冠状动脉介入治疗后危险因素的控制情况分析[J].中国综合临床,2007,23(5):392-394. 被引量:4
  • 5胡大一.心血管疾病预防的新策略和新方向[N].中国医学论坛报,2004-3-25(19).
  • 6Park S J, Park S W, Hong M K, et al. Long-term (three-year) outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function [J]. Am J Cardiol, 2003,91 ( 1 ) : 12-16.
  • 7Tan W A, Tamai H, Park S J, et al. long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients [J]. Circulation, 2001,104(14) : 1609-1614.
  • 8Morice M C, Serrugs P W, Sausa J E, et al. A randomized comparison of a sirolimus-eluting stents with a standard stent for coronary revascularization [J]. N Eng J Med, 2002,346(23):1773 -1780.
  • 9Ellis S G, Popma J J, Lasala M, et al. Relationship between angiographic late loss and target lesion revaseularization after coronary stent implantation: analysis from the TAXUS-Ⅳ trial [J]. J Am Coil Cardiol, 2005,45(8):1193-1200.
  • 10Tsagalou E, Chieffo A, Iakovou I, et al. Multiple overlapping drug eluting stents to treat diffuse disease of the left anterior descending coronary artery [J]. J Am Coll Cardiol, 2005,45(10):1570-1573.

共引文献65

同被引文献43

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部